Zacks: Analysts Expect DENTSPLY SIRONA Inc. (NASDAQ:XRAY) to Announce $0.79 EPS

Equities analysts expect DENTSPLY SIRONA Inc. (NASDAQ:XRAY) to post $0.79 earnings per share (EPS) for the current fiscal quarter, Zacks reports. Seven analysts have provided estimates for DENTSPLY SIRONA’s earnings, with estimates ranging from $0.73 to $0.81. DENTSPLY SIRONA posted earnings per share of $0.87 during the same quarter last year, which suggests a negative year-over-year growth rate of 9.2%. The company is expected to announce its next quarterly earnings report on Monday, March 7th.

On average, analysts expect that DENTSPLY SIRONA will report full year earnings of $2.89 per share for the current financial year, with EPS estimates ranging from $2.84 to $2.92. For the next year, analysts forecast that the company will report earnings of $3.18 per share, with EPS estimates ranging from $2.96 to $3.36. Zacks Investment Research’s earnings per share calculations are an average based on a survey of research firms that follow DENTSPLY SIRONA.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings results on Thursday, November 4th. The medical instruments supplier reported $0.68 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.65 by $0.03. The firm had revenue of $1.07 billion for the quarter, compared to the consensus estimate of $1.02 billion. DENTSPLY SIRONA had a net margin of 9.85% and a return on equity of 13.05%. The business’s revenue was up 19.4% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.67 earnings per share.

XRAY has been the subject of several recent research reports. HC Wainwright dropped their price objective on DENTSPLY SIRONA from $72.00 to $66.00 and set a “neutral” rating for the company in a report on Monday, August 9th. TheStreet upgraded DENTSPLY SIRONA from a “c+” rating to a “b” rating in a research report on Thursday, August 5th. Zacks Investment Research upgraded DENTSPLY SIRONA from a “hold” rating to a “buy” rating and set a $68.00 target price for the company in a research report on Thursday, July 29th. Finally, Barrington Research boosted their price objective on DENTSPLY SIRONA from $77.00 to $79.00 and gave the company an “outperform” rating in a research report on Friday, August 6th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and four have given a buy rating to the company. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $67.57.

In related news, insider Walter Petersohn sold 86,431 shares of DENTSPLY SIRONA stock in a transaction that occurred on Wednesday, November 17th. The stock was sold at an average price of $54.18, for a total transaction of $4,682,831.58. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, SVP Lisa Yankie sold 1,903 shares of DENTSPLY SIRONA stock in a transaction on Friday, November 19th. The stock was sold at an average price of $52.63, for a total value of $100,154.89. The disclosure for this sale can be found here. Company insiders own 0.69% of the company’s stock.

A number of institutional investors have recently modified their holdings of the stock. Liberty Wealth Management LLC bought a new stake in shares of DENTSPLY SIRONA in the second quarter valued at $33,000. Exchange Traded Concepts LLC purchased a new stake in DENTSPLY SIRONA during the 2nd quarter valued at about $36,000. First Command Bank bought a new position in DENTSPLY SIRONA during the 2nd quarter valued at approximately $38,000. Dark Forest Capital Management LP bought a new position in DENTSPLY SIRONA during the 3rd quarter valued at approximately $50,000. Finally, Evermay Wealth Management LLC bought a new position in shares of DENTSPLY SIRONA in the 2nd quarter worth approximately $51,000. Institutional investors and hedge funds own 93.46% of the company’s stock.

NASDAQ:XRAY traded down $0.75 on Thursday, hitting $51.26. 1,163,448 shares of the stock were exchanged, compared to its average volume of 1,437,835. The stock has a market capitalization of $11.21 billion, a price-to-earnings ratio of 26.98, a P/E/G ratio of 0.85 and a beta of 0.88. DENTSPLY SIRONA has a 52 week low of $50.54 and a 52 week high of $69.54. The company has a debt-to-equity ratio of 0.38, a quick ratio of 1.13 and a current ratio of 1.60. The company’s 50-day moving average price is $57.08 and its 200 day moving average price is $61.36.

DENTSPLY SIRONA Company Profile

Dentsply Sirona, Inc engages in the design, manufacture, sales and distribution of professional dental products and technologies. It operates through the following segments: Technologies and Equipment and Consumables. The Technologies and Equipment segments comprises dental technology, equipment and healthcare consumable products such as dental implants, laboratory dental products, computer-aided design and computer-aided manufacturing systems, imaging systems, treatment centers and consumable medical device products.

Further Reading: Straddles

Get a free copy of the Zacks research report on DENTSPLY SIRONA (XRAY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.